Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;39(3):311-6.
doi: 10.1007/s10735-008-9167-0. Epub 2008 Feb 7.

Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical study

Affiliations

Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical study

Clarissa Araújo Silva Gurgel et al. J Mol Histol. 2008 Jun.

Abstract

Aim: To investigate the immunohistochemical expression of Ki-67, p53 and p63 in Keratocyst Odontogenic Tumours (KOTs) in order to contribute to the biological profile of this tumor.

Methods: Immunohistochemical technique was performed using the EnVision System in 37 cases of KOTs.

Results: Ki-67- and p53-immunostained cells were mainly located in the suprabasal layers. p63-positive cells were found throughout the lining cystic epithelium. No difference in the immunostaining for these proteins was observed between primary and recurrent KOTs (Ki-67: P = 0.5591; p53: P = 0.9847; p63: P = 0.9127), or between KOTs associated with Nevoid Basal Cell Carcinoma Syndrome (NBCCS) and sporadic KOTs (Ki-67: P = 0.7013; p53: P = 0.3197; p63: P = 0.2427).

Conclusions: It is possible that biological behavior of KOTs may be related to suprabasal proliferative compartment in the cystic epithelium as observed by high levels of Ki-67, p53 and p63. In addition, p63 immunostaining may represent immaturity of keratinocytes in KOTs, and suggests that this protein may participate in the regulation of epithelial cell differentiation. Taken together, these data may favor tumorigenesis on KOTs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Oral Pathol Med. 1996 May;25(5):249-55 - PubMed
    1. Arch Oral Biol. 1995 Dec;40(12):1081-4 - PubMed
    1. J Oral Pathol Med. 2006 Feb;35(2):75-80 - PubMed
    1. J Oral Pathol Med. 2001 Aug;30(7):434-42 - PubMed
    1. J Oral Maxillofac Surg. 2006 Feb;64(2):308-16 - PubMed

Publication types

LinkOut - more resources